{
  "resourceType": "ValueSet",
  "id": "nehta-nehta-response-to-neoadjuvant-therapy",
  "meta": {
    "lastUpdated": "2015-12-03T08:57:31.744+10:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<div><h2>ResponseToNeoadjuvantTherapy</h2><p>The response of the tumour to neoadjuvant treatment must be recorded.</p><p><b>Copyright Statement:</b> This value set includes content from SNOMED CT, which is copyright Â&copy; 2002+ International         Health Terminology Standards Development Organisation (IHTSDO), and distributed by         agreement    between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this         agreement</p><p>This value set has an inline code system http://hl7.org/fhir/nehta-response-to-neoadjuvant-therapy, which defines the following codes:</p><table class=\"codes\"><tr><td><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td>no_prior_treatment<a name=\"no_prior_treatment\"> </a></td><td>No prior treatment</td><td>No prior treatment</td></tr></table><p>In addition, this value set includes codes from other code systems:</p><ul><li>Include these codes as defined in http://snomed.info/sct<table><tr><td><b>Code</b></td><td><b>Display</b></td></tr><tr><td>444431007</td><td>Grade 0 on a scale of 0 to 3 (qualifier value)</td><td/></tr><tr><td>444456001</td><td>Grade 1 on a scale of 0 to 3 (qualifier value)</td><td/></tr><tr><td>444457005</td><td>Grade 2 on a scale of 0 to 3 (qualifier value)</td><td/></tr><tr><td>444447009</td><td>Grade 3 on a scale of 0 to 3 (qualifier value)</td><td/></tr></table></li></ul></div>"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-oid",
      "valueUri": "urn:oid:2.16.840.1.113883.4.642.2.0"
    }
  ],
  "url": "http://hl7.org/fhir/ValueSet/nehta-nehta-response-to-neoadjuvant-therapy",
  "_url": {
    "fhir_comments": [
      " DMc ?? SR says to make into a NEHTA oid ",
      "<extension url=\"http://hl7.org/fhir/StructureDefinition/valueset-oid\">\n    <valueUri value=\"urn:oid:2.16.840.1.113883.3.88.12.80.67\"/>   \n    </extension>"
    ]
  },
  "version": "20150625",
  "name": "ResponseToNeoadjuvantTherapy",
  "status": "draft",
  "experimental": true,
  "publisher": "HL7 (FHIR Project)",
  "contact": [
    {
      "telecom": [
        {
          "system": "other",
          "value": "http://hl7.org/fhir"
        },
        {
          "system": "email",
          "value": "fhir@lists.hl7.org"
        }
      ]
    }
  ],
  "date": "2015-06-11T16:01:03+10:00",
  "description": "The response of the tumour to neoadjuvant treatment must be recorded.",
  "copyright": "This value set includes content from SNOMED CT, which is copyright © 2002+ International         Health Terminology Standards Development Organisation (IHTSDO), and distributed by         agreement    between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this         agreement",
  "codeSystem": {
    "fhir_comments": [
      "<concept>\n            <code value=\"grade_0_complete_response\"/>\n            <display value=\"Grade 0 (complete response) No viable cancer cells\"/>\n            <definition value=\"Grade 0 (complete response) No viable cancer cells\"/>\n        </concept>\n        <concept>\n            <code value=\"grade_1_moderate_response\"/>\n            <display value=\"Grade 1 (moderate response) Single cells or small groups of cancer cells\"/>\n            <definition value=\"Grade 1 (moderate response) Single cells or small groups of cancer cells\"/>\n        </concept>\n        <concept>\n            <code value=\"grade_2_minimal_response\"/>\n            <display value=\"Grade 2 (minimal response) Residual cancer outgrown by fibrosis\"/>\n            <definition value=\"Grade 2 (minimal response) Residual cancer outgrown by fibrosis\"/>\n        </concept>\n        <concept>\n            <code value=\"grade_3_poor_response\"/>\n            <display value=\"Grade 3 (poor response) Minimal or no tumour kill; extensive residual cancer.\"/>\n            <definition value=\"Grade 3 (poor response) Minimal or no tumour kill; extensive residual cancer.\"/>\n        </concept>"
    ],
    "system": "http://hl7.org/fhir/nehta-response-to-neoadjuvant-therapy",
    "_system": {
      "fhir_comments": [
        " These result values are from  \n            Ryan R, Gibbons D and Hyland JMP (2005). Pathological response following long-course neoadjuvant \n            chemoradiotherapy for locally advanced rectal cancer. Histopathology(47):141-146.  ",
        " DMc ?? SR says to make into a NEHTA oid ",
        "<extension url=\"http://hl7.org/fhir/StructureDefinition/valueset-oid\">\n            <valueUri value=\"urn:oid:2.16.840.1.113883.3.88.12.80.67\"/>   \n        </extension>"
      ]
    },
    "version": "20150625",
    "caseSensitive": true,
    "concept": [
      {
        "code": "no_prior_treatment",
        "display": "No prior treatment",
        "definition": "No prior treatment"
      }
    ]
  },
  "compose": {
    "include": [
      {
        "system": "http://snomed.info/sct",
        "concept": [
          {
            "code": "444431007",
            "display": "Grade 0 on a scale of 0 to 3 (qualifier value)"
          },
          {
            "code": "444456001",
            "display": "Grade 1 on a scale of 0 to 3 (qualifier value)"
          },
          {
            "code": "444457005",
            "display": "Grade 2 on a scale of 0 to 3 (qualifier value)"
          },
          {
            "code": "444447009",
            "display": "Grade 3 on a scale of 0 to 3 (qualifier value)"
          }
        ]
      }
    ]
  }
}